Medeon Biodesign, Inc. (TPEX:6499)

Medeon Biodesign Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,260	3,654	4,294	5,092	6,592	3,642
Market Cap Growth	119.43%	-14.91%	-15.67%	-22.76%	80.99%	-13.33%
Enterprise Value	8,627	2,482	2,208	3,643	4,155	2,451
Last Close Price	100.50	39.26	46.19	54.26	69.38	38.45
PE Ratio	-	-	-	-	3.17	-
PS Ratio	23.48	12.48	21.88	17.07	95.60	29.60
PB Ratio	8.18	2.38	1.81	1.39	1.57	1.38
P/TBV Ratio	9.78	2.69	2.00	1.49	1.63	1.99
EV/Sales Ratio	21.87	8.48	11.25	12.21	60.25	19.92
EV/FCF Ratio	-11.00	-	-	-	-	-
Debt / Equity Ratio	0.12	0.11	0.08	0.05	0.01	0.19
Asset Turnover	0.21	0.13	0.06	0.07	0.02	0.04
Inventory Turnover	13.06	9.33	17.47	-	-	1.94
Quick Ratio	4.75	5.81	9.89	8.09	14.76	11.93
Current Ratio	5.03	6.11	10.05	8.25	14.91	12.25
Return on Equity (ROE)	-52.18%	-44.56%	-42.09%	-12.66%	-17.16%	-14.19%
Return on Assets (ROA)	-27.34%	-23.94%	-15.46%	-7.26%	-8.07%	-7.33%
Return on Capital (ROIC)	-29.71%	-25.97%	-16.35%	-7.55%	-8.42%	-7.76%
Earnings Yield	-8.09%	-22.05%	-28.06%	-8.52%	31.53%	-5.29%
FCF Yield	-8.47%	-24.82%	-18.87%	-11.82%	-4.58%	-4.71%
Dividend Yield	-	-	-	0.88%	1.14%	-
Buyback Yield / Dilution	-0.19%	-0.11%	-0.02%	0.07%	-0.48%	-0.05%
Total Shareholder Return	-0.19%	-0.11%	-0.02%	0.95%	0.66%	-0.05%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.